Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet Lond Engl. 2025;405(10478):583–96.

Article  Google Scholar 

Ständer S. Atopic dermatitis. N Engl J Med. 2021;384(12):1136–43.

Article  PubMed  Google Scholar 

Augustin M, Misery L, von Kobyletzki L, Armario-Hita JC, Mealing S, Redding M. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol JEADV. 2022;36(Suppl 7):3–16.

Article  PubMed  Google Scholar 

Eyerich K, Gooderham MJ, Silvestre JF, Shumack SP, Mendes-Bastos P, Aoki V, et al. Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study. J Eur Acad Dermatol Venereol JEADV. 2024;38(2):340–53.

Article  PubMed  Google Scholar 

AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel, Chu DK, Schneider L, Asiniwasis RN, Boguniewicz M, De Benedetto A, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2024;132(3):274–312.

Chu DK, Chu AWL, Rayner DG, Guyatt GH, Yepes-Nuñez JJ, Gomez-Escobar L, et al. Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023;152(6):1493–519.

Article  CAS  PubMed  Google Scholar 

Drucker AM. Treatment of atopic dermatitis. JAMA. 2025;334(12):1103–4.

Article  PubMed  Google Scholar 

Sidbury R, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Drucker AM, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):e1-20.

Article  CAS  PubMed  Google Scholar 

Halling AS, Loft N, Silverberg JI, Guttman-Yassky E, Thyssen JP. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis. J Am Acad Dermatol. 2021;84(1):139–47.

Article  CAS  PubMed  Google Scholar 

Gooderham MJ, Hong HCH, Eshtiaghi P, Papp KA. Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3 Suppl 1):S28-36.

Article  CAS  PubMed  Google Scholar 

Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130–9.

Article  PubMed  Google Scholar 

He Q, Xie X, Chen Q, Li W, Song Z, Wang X, et al. Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses. Front Immunol. 2024;15:1342810.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, et al. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. J Am Acad Dermatol. 2024;90(2):e43-56.

Article  CAS  PubMed  Google Scholar 

Alvarenga JM, Bieber T, Torres T. Emerging biologic therapies for the treatment of atopic dermatitis. Drugs. 2024;84(11):1379–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silverberg JI, Mohawk JA, Cirulli J, Nograles K, Punzalan JC, Kelly KM, et al. Burden of disease and unmet needs in atopic dermatitis: results from a patient survey. Dermat Contact Atopic Occup Drug. 2023;34(2):135–44.

Google Scholar 

Yilmaz O, Torres T. Extended half-life antibodies: a narrative review of a new approach in the management of atopic dermatitis. Dermatol Ther. 2024;14(9):2393–406.

Article  Google Scholar 

Müller S, Maintz L, Bieber T. Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs. Allergy. 2024;79(6):1501–15.

Article  PubMed  Google Scholar 

de Bruin-Weller MS, Boesjes CM, Achten RA, Beck LA, Irvine AD, Vestergaard C, et al. Biologics to treat atopic dermatitis: effectiveness, safety, and future directions. Allergy. 2026;81(2):326–344.

Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet Lond Engl. 2020;396(10247):345–60.

Article  CAS  Google Scholar 

Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.

Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134(4):769–79.

Article  PubMed  PubMed Central  Google Scholar 

Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315–27.

Article  CAS  PubMed  Google Scholar 

Schuler CF, Tsoi LC, Billi AC, Harms PW, Weidinger S, Gudjonsson JE. Genetic and immunological pathogenesis of atopic dermatitis. J Invest Dermatol. 2024;144(5):954–68.

Article  CAS  PubMed  Google Scholar 

Schmuth M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, Blunder S, Trafoier T, et al. Skin barrier in atopic dermatitis. J Invest Dermatol. 2024;144(5):989-1000.e1.

Article  CAS  PubMed  Google Scholar 

Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):266–78.

Article  CAS  PubMed  Google Scholar 

Michaelidou M, Redhu D, Kumari V, Babina M, Worm M. IL-1α/β and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2023;37(9):e1141–3.

Article  CAS  PubMed  Google Scholar 

Bertschi NL, Bazzini C, Schlapbach C. The concept of pathogenic TH2 cells: collegium internationale allergologicum update 2021. Int Arch Allergy Immunol. 2021;182(5):365–80.

Article  CAS  PubMed  Google Scholar 

Bähler L, Schärli S, Luther F, Bertschi NL, Skabytska Y, Roediger B, et al. IL-18 in atopic dermatitis-a multifaceted driver of skin inflammation. J Allergy Clin Immunol. 2025;156(5):1160–72.

Article  PubMed  Google Scholar 

Guttman-Yassky E, Croft M, Geng B, Rynkiewicz N, Lucchesi D, Peakman M, et al. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis. Br J Dermatol. 2024;191(4):488–96.

Article  CAS  PubMed  Google Scholar 

Gandhi NA, Bennett BL, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35–50.

Article  CAS  PubMed  Google Scholar 

Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752–60.

Article  CAS  PubMed  Google Scholar 

Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol. 2017;48:68–73.

Article  CAS  PubMed  Google Scholar 

Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009;9(7):480–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He H, Guttman-Yassky E. JAK inhibitors for atopic dermatitis: an update. Am J Clin Dermatol. 2019;20(2):181–92.

Article  PubMed  Google Scholar 

Facheris P, Jeffery J, Del Duca E, Guttman-Yassky E. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. Cell Mol Immunol. 2023;20(5):448–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Möbus L, Rod